Metal Drugs and the Anticancer Immune Response
Open accessThe DOI matches its Crossref record; 1,300 of the 1,300 references it cites were found in a registry or an index.
Abstract
The immune system deploys a multitude of innate and adaptive mechanisms not only to ward off pathogens but also to prevent malignant transformation ("immune surveillance"). Hence, a clinically apparent tumor already reflects selection for those malignant cell clones capable of evading immune recognition ("immune evasion"). Metal drugs, besides their well-investigated cytotoxic anticancer effects, massively interact with the cancer-immune interface and can reverse important aspects of immune evasion. This topic has recently gained intense attention based on combination approaches with anticancer immunotherapy (e.g., immune checkpoint inhibitors), a strategy recently delivering first exciting results in clinical settings. This review summarizes the promising but still extremely fragmentary knowledge on the interplay of metal drugs with the fidelity of anticancer immune responses but also their role in adverse effects. It highlights that, at least in some cases, metal drugs can induce long-lasting anticancer immune responses. Important steps in this process comprise altered visibility and susceptibility of cancer cells toward innate and adaptive immunity, as well as direct impacts on immune cell populations and the tumor microenvironment. On the basis of the gathered information, we suggest initiating joint multidisciplinary programs to implement comprehensive immune analyses into strategies to develop novel and smart anticancer metal compounds.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Items 1,201–1,300 of 1,300
Platinum Group Elements Enhance the Allergic Immune Response by Acting on Dendritic Cells
Paolucci, C., Ponti, J., Fabbri, M., Breda, D., Sabbioni, E., & Burastero, S. E. (2007) · International Archives of Allergy and Immunology · doi:10.1159/000099466 · Cited by 16
Biochemotherapy of metastatic malignant melanoma. On down-regulation of CD28
Håkansson, A., Håkansson, L., Gustafsson, B., Krysander, L., Rettrup, B., Ruiter, D. J., & Bernsen, M. R. (2002) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0304-4 · Cited by 16
Sodhi, A., & SURESH, A. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb06989.x · Cited by 16
Stordal, B., Peters, G. B., & Davey, R. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20373 · Cited by 16
Anti-tumor and immunomodulatory activity of iron hepta-tungsten phosphate oxygen clusters complex
Zhang, B., Qiu, J., Wu, C., Li, Y., & Liu, Z. (2015) · International Immunopharmacology · doi:10.1016/j.intimp.2015.11.003 · Cited by 16
Sava, G., Zorzet, S., Mestroni, G., & Zassinovich, G. (1985) · PubMed · Cited by 16
Zhu, H. H., Liu, Y., Hong, H., Wang, W., & Liu, F. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.045 · Cited by 16
Fuereder, T., & Berger, W. (2017) · ESMO Open · doi:10.1136/esmoopen-2017-000239 · Cited by 16
Self-citationInhibition of early T cell cytokine production by arsenic trioxide occurs independently of Nrf2
VanDenBerg, K. R., Freeborn, R. A., Liu, S., Kennedy, R. C. M., Zagorski, J. W., & Rockwell, C. E. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185579 · Cited by 16
Banerjee, K., Biswas, M. K., & Choudhuri, S. K. (2017) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-017-1498-4 · Cited by 16
Stojanovska, V., McQuade, R. M., Miller, S., & Nurgali, K. (2018) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155418774755 · Cited by 16
In vitro immunomodulatory activity of ruthenium complexes
Newcomb, J. R., Rivnay, B., Bastos, C. M., Ocain, T. D., Gordon, K. A., Gregory, P., Turci, S. M., Sterne, K. A., Jesson, M. I., Krieger, J. I., et al. (2003) · Inflammation Research · doi:10.1007/s00011-003-1169-5 · Cited by 15
Palma, J. P., & Aggarwal, S. K. (1994) · Anti-Cancer Drugs · doi:10.1097/00001813-199412000-00002 · Cited by 15
Protein kinase C: a potential pathway of macrophage activation with cisplatin
Shishodia, S., Shrivastava, A., & Sodhi, A. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00017-0 · Cited by 15
Chemotherapy-Related Secondary Acute Myeloid Leukemia in Patients Diagnosed With Osteosarcoma
Escudero, M. C., Lassaletta, Á., Sevilla, J., Fernández‐Plaza, S., Pérez‐Martínez, A., Díaz, M. Á., & Madero, L. (2004) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200407000-00012 · Cited by 15
Gd@C82(OH)22 Nanoparticles Constrain Macrophages Migration Into Tumor Tissue to Prevent Metastasis
Song, Y., Jin, J., Li, J., He, R., Zhang, M., Chang, Y., Chen, K., Wang, Y., Sun, B., & Xing, G. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.8277 · Cited by 15
Yan, G., Xi, Y., Xu, S., Lin, Y., Chen, J., Dai, H., Xia, J., Li, C., Li, Q., Li, Z., et al. (2013) · Immunological Investigations · doi:10.3109/08820139.2013.801986 · Cited by 15
Oxaliplatin-Induced Ototoxicity in Adjuvant Setting for Colorectal Cancer: Unusual Side Effect
Hijri, F. Z., Arifi, S., Ouattassi, N., Mellas, N., & Mesbahi, O. E. (2013) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-013-9489-3 · Cited by 15
Paladini, F., Cocco, E. E., Potolicchio, I., Fazekasova, H., Lombardi, G., Fiorillo, M. T., & Sorrentino, R. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq328 · Cited by 15
Matczuk, M., Kupiec, M., Legat, J., Pawlak, K., Timerbaev, A. R., & Jarosz, M. (2015) · The Analyst · doi:10.1039/c5an00426h · Cited by 15
Taroni, A. (2017) · Nature Chemistry · doi:10.1038/nchem.2787 · Cited by 15
Analysis of cytotoxic effects of nickel on human blood lymphocytes
Zarei, M. H., Shirazi, S. F. H., Aghvami, M., Salimi, A., & Pourahmad, J. (2017) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2017.1364314 · Cited by 15
Origins of natural killer cell memory: special creation or adaptive evolution
Holder, K. A., Comeau, E. M., & Grant, M. D. (2018) · Immunology · doi:10.1111/imm.12898 · Cited by 15
A pharmacokinetic and phase II study of gallium nitrate in patients with non-small cell lung cancer
Webster, L. K., Olver, I., Stokes, K. H., Sephton, R. G., Hillcoat, B. L., & Bishop, J. F. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/pl00006743 · Cited by 14
Williame, L. M. E., Joos, R., Proot, F., & Immesoete, C. (1987) · Clinical Rheumatology · doi:10.1007/bf02330601 · Cited by 14
Synthesis, Immunomodulation and Cytotoxic Effects of Vanadium (IV) Complexes
Ashiq, U., Jamal, R. A., Mesaik, M. A., Mahroof-Tahir, M., Shahid, S., & Khan, K. M. (2014) · Medicinal Chemistry · doi:10.2174/15734064113099990033 · Cited by 14
The anticancer drug Dp44mT inhibits T‐cell activation and CD25 through a copper‐dependent mechanism
Gundelach, J. H., Madhavan, A. A., Wettstein, P. J., & Bram, R. J. (2012) · The FASEB Journal · doi:10.1096/fj.12-215756 · Cited by 14
Kim, J., Jang, M. J., Lee, J.-I., Chung, Y. H., Jeong, J. H., Hung, C., & Kim, D. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182328569 · Cited by 14
Acute Myeloid Leukemia After Radium-223 Therapy: Case Report
Varkaris, A. S., Gunturu, K. S., Kewalramani, T., & Tretter, C. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.11.002 · Cited by 14
Cabrera, A. R., Espinosa‐Bustos, C., Faúndez, M., Meléndez, J., Jaque, P., Daniliuc, C. G., Aguirre, A., Rojas, R. S., & Salas, C. O. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.06.001 · Cited by 14
Anti-inflammatory activity of electron-deficient organometallics
Zhang, J., Pitto‐Barry, A., Shang, L., & Barry, N. P. E. (2017) · Royal Society Open Science · doi:10.1098/rsos.170786 · Cited by 14
Av, S., Kostevich, V. A., Varfolomeeva, E. Y., Grigorieva, D. V., Gorudko, I. V., Kozlov, S. O., Kudryavtsev, I. V., Mikhalchik, E. V., Filatov, M. V., Cherenkevich, S. N., et al. (2018) · Biochemistry and Cell Biology · doi:10.1139/bcb-2017-0277 · Cited by 14
Balogh, L. P. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.02.005 · Cited by 14
Immunosuppressant effect of gold on IgG subclasses and IgE; evidence for sparing of Th2 responses
Kiely, P. D. W., HELBERT, M., Miles, J., & Oliveira, D. B. G. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01207.x · Cited by 13
Pasello, G., Urso, L., Silic‐Benussi, M., Schiavon, M., Cavallari, I., Marulli, G., Nannini, N., Rea, F., Ciminale, V., & Favaretto, A. G. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000198 · Cited by 13
Mechanism of NF-κB translocation in macrophages treated in vitro with cisplatin
Sodhi, A., & Singh, R. A. (1998) · Immunology Letters · doi:10.1016/s0165-2478(98)00043-1 · Cited by 13
Chronic myeloid leukemia following the treatment of rectal adenocarcinoma
Kadıköylü, G., Yavaşoğlu, İ., Barutça, S., Meydan, N., & Bolaman, Z. (2008) · Medical Oncology · doi:10.1007/s12032-008-9061-3 · Cited by 13
A missing link in thymic dendritic cell development
Krueger, A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141850 · Cited by 13
Secondary Leukemia After Chemotherapy and/or Radiotherapy for Gynecologic Neoplasia
Shimada, T., Saito, T., Okadome, M., Shimamoto, K., Ariyoshi, K., Eto, T., Tomita, Y., & Kodama, K. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000045 · Cited by 13
Zinzani, P. L., Derenzini, E., Pellegrini, C., Rigacci, L., Fabbri, A., Gandolfi, L., Argnani, L., Casadei, B., Pulsoni, A., Gobbi, M., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr633 · Cited by 13
Therapy‐related leukemia following chemoradiotherapy for esophageal cancer
Mimura, N., Tsujimura, H., Ise, M., Sakai, C., Takagi, T., Nagata, M., & Kumagai, K. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01487.x · Cited by 13
Moragues, M. E., Brines, R., Terencio, M. C., Sancenón, F., Martínez‐Máñez, R., & Alcaraz, M. J. (2013) · Inorganic Chemistry · doi:10.1021/ic401967g · Cited by 13
Secondary acute promyelocytic leukemia following chemotherapy for gastric cancer: A case report
Zhang, Y.-C., Zhou, Y.-Q., Yan, B., Shi, J., Xiu, L.-J., Sun, Y.-W., Liu, X., Qin, Z.-F., Wei, P.-K., & Li, Y.-J. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4402 · Cited by 13
Pharmacological Activities of Ruthenium Complexes Related to Their NO Scavenging Properties
Castellarin, A., Zorzet, S., Bergamo, A., & Sava, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081254 · Cited by 13
Basu, A., Bhattacharjee, A., Hajra, S., Samanta, A., & Bhattacharya, S. (2016) · Redox Report · doi:10.1080/13510002.2016.1260192 · Cited by 13
Effects of arsenic on porcine dendritic cells in vitro
Mehrzad, J., Gharaie, M. H. M., & Taheri, M. (2017) · Journal of Immunotoxicology · doi:10.1080/1547691x.2016.1249985 · Cited by 13
Site-specific expression of amine oxidases in breast cancer metastases
Cha, Y. J., Jung, W. H., & Koo, J. S. (2018) · Tumor Biology · doi:10.1177/1010428318776822 · Cited by 13
Identification of effector cells for TNFα-mediated cytotoxicity against WEHI164S cells
Miyaji, C., Watanabe, H., Miyakawa, R., Yokoyama, H., Tsukada, C., Ishimoto, Y., Miyazawa, S., & Abo, T. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00525-7 · Cited by 12
Sartor, O. A. (2011) · Asian Journal of Andrology · doi:10.1038/aja.2011.23 · Cited by 12
Class I histocompatibility antigen expression: A prognostic factor for aneuploid ovarian cancers
Moore, D. H., Fowler, W. C., & Olafsson, K. (1990) · Gynecologic Oncology · doi:10.1016/0090-8258(90)90091-x · Cited by 12
Oxaliplatin and ototoxicity: is it really safe for hearing?
Yüce, S., ŞEKER, M. M., Koç, S., Uysal, İ. Ö., Kaçan, T., Doğan, M., Doğan, M., Babacan, N. A., & Kılıçkap, S. (2014) · TURKISH JOURNAL OF MEDICAL SCIENCES · doi:10.3906/sag-1304-76 · Cited by 12
Bergamo, A., Delfino, R., Casarsa, C., & Sava, G. (2012) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152012802650039 · Cited by 12
Rath, S., Anand, A., Ghosh, N., Das, L., Kokate, S. B., Dixit, P., Majhi, S., Rout, N., Singh, S. P., & Bhattacharyya, A. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.01.140 · Cited by 12
Rani, N., Bharti, S., Tomar, A., Dinda, A. K., Arya, D. S., & Bhatia, J. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1228923 · Cited by 12
Ohtake, S., Kawahara, T., Kasahara, R., Ito, H., Osaka, K., Hattori, Y., Teranishi, J.-I., Makiyama, K., Mizuno, N., Umemoto, S., et al. (2016) · BioMed Research International · doi:10.1155/2016/9846823 · Cited by 12
Xu, W., Li, X., Quan, L., Yao, J., Mu, G., Guo, J., & Wang, Y. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1346253 · Cited by 12
Hu, Z., Hu, S., Wu, Y., Li, S., He, C., Xing, X., Wang, Y., & Du, X. (2018) · Oncology Letters · doi:10.3892/ol.2018.7974 · Cited by 12
Lou, Y., Lu, Y., Zhu, Z., Ma, Y., Suo, S., Wang, Y., Chen, D., Tong, H., Qian, W., Meng, H., et al. (2018) · Hematological Oncology · doi:10.1002/hon.2519 · Cited by 12
Li, C., Guan, T., Gao, C., Lin, Y., Yan, G., Zhu, M., Lv, C.-S., Xia, J., & Qi, Z. (2015) · Transplant Immunology · doi:10.1016/j.trim.2015.05.004 · Cited by 11
Biological activity of metal complexes
Aresta, M., Fazio, M. D., Fumarulo, R., Giordano, D., Pantaleo, R., & Riccardi, S. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(82)91948-9 · Cited by 11
Self/non‐self discrimination and the problem of keeping T cells alive
Sprent, J., & Cho, J. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100139 · Cited by 11
Cui, W., Cui, H., Peng, X., Fang, J. S., Zuo, Z., Liu, X., & Wu, B. (2010) · Biological Trace Element Research · doi:10.1007/s12011-010-8890-z · Cited by 11
Sepsis and treatment-induced immunosuppression in the patient with cancer
Reigle, B. S., & Dienger, M. J. (2003) · Critical Care Nursing Clinics of North America · doi:10.1016/s0899-5885(02)00038-2 · Cited by 10
Yoshimoto, K., Kishida, T., Nakano, H., Matsui, M., Shin‐Ya, M., Shimada, T., Nakai, S., Imanishi, J., Takeuchi, M., Hisa, Y., et al. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318204ed70 · Cited by 10
Cisplatin and carboplatin-mediated activation of murine peritoneal macrophages in vitro
Palma, J. P., & Aggarwal, S. K. (1995) · Anti-Cancer Drugs · doi:10.1097/00001813-199504000-00016 · Cited by 10
Tsai, C., Qiu, J.-T. T., Tseng, C., & Hsu, Y. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12515 · Cited by 10
Odo, U., Vasudevamurthy, A. K., & Sartor, O. A. (2016) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2016.12.028 · Cited by 10
Immunogenomics: using genomics to personalize cancer immunotherapy
Siniard, R. C., & Harada, S. (2017) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-017-2140-0 · Cited by 10
Wang, X., Li, Y., Lin, M., Jin, J., & Huang, Z. (2017) · BioMetals · doi:10.1007/s10534-017-0056-4 · Cited by 10
Sava, G., Salerno, G., Bergamo, A., Cocchietto, M., Gagliardi, R., Alessio, E., & Mestroni, G. (1995) · Metal-Based Drugs · doi:10.1155/mbd.1996.67 · Cited by 9
Effect of gold compounds on the activity of adenylyl cyclase in human lymphocyte membranes
Lazarevic, M. B., Yan, K., Swedler, W. I., Rasenick, M. M., & Skosey, J. L. (1992) · Arthritis & Rheumatism · doi:10.1002/art.1780350803 · Cited by 9
Therapy-Related Myelodysplasia and Acute Leukemia
Peedersen-Bjergaard, J. (1995) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199509052696 · Cited by 9
Tilakaratne, D., & Sidhu, S. (2014) · Australasian Journal of Dermatology · doi:10.1111/ajd.12182 · Cited by 8
Holman, L. L., Ren, Y., & Westin, S. N. (2015) · BMC Cancer · doi:10.1186/s12885-015-1755-2 · Cited by 8
Singh, R. A. K., & Sodhi, A. (1999) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1999.00841.x · Cited by 8
LFA‐1‐dependent tumoricidal activity of cisplatin‐treated macrophages
Singh, R. A., & Sodhi, A. (1998) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.1998.00751.x · Cited by 8
Iavicoli, I., Sgambato, A., Fontana, L., Marinaccio, A., Leso, V., Corbi, M., Bergamaschi, A., & Calabrese, E. J. (2012) · Bulletin of Environmental Contamination and Toxicology · doi:10.1007/s00128-012-0720-x · Cited by 8
Bigoni, R., Cuneo, A., Roberti, M. G., Moretti, S., Angeli, C. D., Dabusti, M., Campioni, D., SENNO, L. D., Biondi, A., Chaplin, T., et al. (1999) · Leukemia · doi:10.1038/sj.leu.2401391 · Cited by 8
Momčilović, M. B., Eichhorn, T. A., Blaževski, J., Schmidt, H., Kaluđerović, G. N., & Stošić‐Grujičić, S. (2015) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-015-1242-x · Cited by 8
Acute Myeloid Leukemia Secondary to Oxaliplatin Treatment for Esophageal Cancer
Damodaran, S., Bellavia, T., Sait, S. N. J., Wang, E. S., Wetzler, M., & Khushalani, N. I. (2011) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2011.09.002 · Cited by 7
Powell, C. B., Mutch, D. G., Kao, M. S., & Collins, J. L. (1990) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1990.tb08106.x · Cited by 7
A new strategy to target regulatory T cells in solid tumors
Thomas‐Schoemann, A., Batteux, F., & Alexandre, J. (2013) · OncoImmunology · doi:10.4161/onci.23338 · Cited by 7
Expression of LFA-1 adhesion molecules on cisplatin-treated macrophages
Shrivastava, A., Shishodia, S., & Sodhi, A. (1998) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(98)00025-1 · Cited by 7
Öhrström, L. R. (2015) · Nature Chemistry · doi:10.1038/nchem.2428 · Cited by 7
Injectable Gold - Induced Hepatitis and Neutropenia in Rheumatoid Arthritis
Uhm, W. S., Yoo, D., Lee, J. H., Kim, T., Jun, J. B., Lee, I. H., Bae, S., & Kim, S. Y. (2000) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2000.15.2.156 · Cited by 6
Huang, X., Guan, D., Shu, Y., Liu, L., & Ni, F. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.10.4329 · Cited by 6
Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems
Toren, A., Pismenyuk, T., Yalon, M., Freedman, S., Simon, A. J., Fisher, T., Moshe, I., Reichardt, J. K. V., Constantini, S., Mardor, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11382 · Cited by 6
Picciotto, M., Franchina, T., Russo, A., Ricciardi, G. R. R., Provazza, G., Sava, S., Baldari, S., Caffo, O., & Adamo, V. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1323875 · Cited by 6
Wang, L., Liang, W., Peng, N., Hu, X., Xu, Y., & Liu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.22757 · Cited by 6
Cytotoxic Activity of Gd(III)‐ and Dy(III)‐Complexes
Kostova, I. P., Kiefer, W., & Momekov, G. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200700118 · Cited by 5
Merlin, F., Prochilo, T., Kildani, B., Tucci, A., Ferrari, S., Rossi, G., D'Adda, P., & Beretta, G. D. (2008) · Acta Oncologica · doi:10.1080/02841860701558864 · Cited by 5
Xing, G., Miller, C. J., Pham, A. N., Jones, A. M., & Waite, T. D. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.08.007 · Cited by 5
Kostevich, V. A., & Av, S. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.08.003 · Cited by 5
Gąsiorowski, K., Brokos, B., Szyba, K., Woźniak, D., Fraser, D. M., Zakeeruddin, S. M., & Grätzel, M. (1999) · BioMetals · doi:10.1023/a:1009238611562 · Cited by 4
Liu, W. M., Fowler, D. W., Smith, P., & Dalgleish, A. G. (2010) · Cancer Research · doi:10.1158/1538-7445.am10-5612 · Cited by 4
Platinum compounds and therapy related acute promyelocytic leukemia
Martin, J. R., & Majumdar, G. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200198 · Cited by 4
Samanta, D. R., Senapati, S. N., Sharma, P., Mohanty, A., & Samantaray, S. (2009) · Journal of Cancer Research and Therapeutics · doi:10.4103/0973-1482.59918 · Cited by 4
Impairment of Antigen-Specific T Cell Proliferative Response in B Cell Suppressed Mice
Ron, Y., BAETSELIER, P. D., Gordon, J., Feldman, M., & Segal, S. (1982) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-9066-4_84 · Cited by 3
Immune functions and gold-induced enterocolitis
Stillman, A. E., & Dubey, D. P. (1988) · Digestive Diseases and Sciences · doi:10.1007/bf01536006 · Cited by 3
Arinaga, S., Ueo, H., Go, H., & Akiyoshi, T. (1997) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.1997.12.371 · Cited by 2
Research works printed but not linked: 47
- van der Most R. G., 2005, Discovery Medicine, 5, 265
- Alberts B., 2015, Mol. Biol. Cell
- Seliger B., 1996, Exp. Hematol., 24, 1275
- Fink D., 1996, Cancer Res., 56, 4881
- Yoshikawa A., 1997, Kobe J. Med. Sci., 43, 109
- 10.1007/s00775-018- 1546-8 · doi:10.1007/s00775-018-
- Rosenberg, B. In Advances in Antimicrobial and Antineoplastic Chemotherapy, University Park Press: Baltimore, 1972; Vol. 11.
- 10.1002/(SICI)1098-2264(199704)18:4<286::AID-GCC6>3.0.CO;2-X · doi:10.1002/(sici)1098-2264(199704)18:4<286::aid-gcc6>3.0.co;2-x
- Dempsey J. L., 1985, Cancer Res., 45, 2873
- Nio Y., 2000, Anticancer Res., 20, 3293
- Qin X., 2010, Cell. Mol. Biol. (Noisy- le-grand), 56, 1366
- Kleinerman E. S., 1980, Cancer Res., 40, 3099
- Lichtenstein A. K., 1986, Cancer Res., 46, 639
- 10.1002/1097-0142(19930215)71:4<1313::AID-CNCR2820710424>3.0.CO;2-# · doi:10.1002/1097-0142(19930215)71:4<1313::aid-cncr2820710424>3.0.co;2-#
- Yamaue H., 1991, J. Clin. Lab. Immunol., 35, 165
- 10.1002/(SICI)1097-0215(19971104)73:3<416::AID-IJC17>3.0.CO;2-A · doi:10.1002/(sici)1097-0215(19971104)73:3<416::aid-ijc17>3.0.co;2-a
- Jiang J., 2006, Anticancer Res., 26, 2237
- Ujiie T., 1989, Jpn. J. Exp. Med., 59, 17
- Maeda K., 2011, Anticancer Res., 31, 4569
- Miller W. H., 2002, Cancer Res., 62, 3893
- 10.1097/CJI.0b013e3181755deb · DOI
- Kreuser E. D., 1992, Semin. Oncol., 19, 73
- Magnarin M., 2000, Anticancer Res., 20, 2939
- Nardon C., 2014, Anticancer Res., 34, 487
- Hashimoto K., 1994, J. Rheumatol., 21, 1020
- Yan A., 1990, J. Rheumatol., 17, 47
- Wang X. D., 2009, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 17, 533
- 10.1371/journal.pone.0100933 · DOI · Paper page
- Korbecki J., 2012, Acta Biochim. Polym., 59, 195
- 10.3109/1547691X.2014.996681 · DOI
- Desoize B., 2004, Anticancer Res., 24, 1529
- Sava G., 1985, Anticancer Res., 5, 249
- Boscolo P., 2004, Ann. Clin. Lab. Sci., 34, 299
- Brewer G. J., 2000, Clin. Cancer Res., 6, 1
- Redman B. G., 2003, Clin. Cancer Res., 9, 1666
- Pan Q., 2003, Mol. Cancer Res., 1, 701
- Lukasewycz O. A., 1982, J. Natl. Cancer Inst., 69, 489
- 10.1515/9783110470734-016 · doi:10.1515/9783110470734-016
- Eriksson M., 2009, Anticancer Res., 29, 11
- Signat B., 2011, Curr. Issues Mol. Biol., 13, 25
- Sonis S. T., 2004, J. Support. Oncol., 2, 21
- 10.1053/sonc.2002.35524 · doi:10.1053/sonc.2002.35524 · Paper page
- Juhn S. K., 2001, Int. Tinnitus J., 7, 72
- Boussios S., 2012, Ann. Gastroenterol., 25, 106
- Takeyama K., 2000, Int. J. Hematol., 71, 144
- Giles F. J., 1994, Curr. Opin. Hematol., 1, 256
- Lu J., 2017, Ochsner J., 17, 379
Cited by
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Toxicity of gold nanoparticles (AuNPs): A review
Sani, A., Cao, C., & Cui, D. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100991 · Cited by 454
Classification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
New Designs for Phototherapeutic Transition Metal Complexes
Imberti, C., Zhang, P., Huang, H., & Sadler, P. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201905171 · Cited by 443
The immune microenvironment in cartilage injury and repair
Li, M., Yin, H., Yan, Z., Li, H., Wu, J., Wang, Y., Wei, F., Tian, G., Ning, C., Li, H., et al. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.12.006 · Cited by 403
Metadata
- Authors
- Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W.
- Affiliations
- Comprehensive Cancer Center Vienna (AT)
- University of Vienna (AT)
- Corresponding author
- Berger, Walter
- ORCID
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-11-29
- Volume
- 119
- Issue
- 2
- Pages
- 1519-1624
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2903051221
- Cited by
- 355
- References
- 1,298
- Citations by year
- 2026: 28 · 2025: 44 · 2024: 47 · 2023: 51 · 2022: 49 · 2021: 45 · 2020: 53 · 2019: 38
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Chemical Reviews (publishedVersion)
- PubMed (publishedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion, other-oa)
- Funders
- FP7 People: Marie-Curie Actions (609431)
- Universit?t Wien
- Medizinische Universit?t Wien
- Johanna Mahlke, geb. Obermann-Stiftung zur F?rderung der Krebsforschung an der Universit?t Wien
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- metal-based anticancer agents, antitumor immunity, immune surveillance, immune evasion, cancer immunotherapy, immune checkpoint inhibitors, tumor microenvironment, innate and adaptive immunity
- MeSH terms
- Gastrointestinal Microbiome, Antineoplastic Agents, Humans, Immunity, Innate, Immunotherapy, Lymphocytes, Metals, Neoplasms, Nanoparticles, Coordination Complexes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.